SCHEMBL17200992

SCHEMBL17200992

COc1ccc(/C(O)=C\C(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.61
CA2 P00918 5/20 0.61
CES2 O00748 2/20 0.57
CES1 P23141 2/20 0.57
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
GAA P10253 2/20 0.55
PARP1 P09874 1/20 0.53
PARP10 Q53GL7 1/20 0.53
PARP2 Q9UGN5 1/20 0.53
PARP4 Q9UKK3 1/20 0.53
THRB P10828 1/20 0.52
ATM Q13315 1/20 0.52
PLK1 P53350 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MAPT P10636 1/20 0.49
HSPD1 P10809 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17714706 1.00 CA1 (0.61) CA1CA2CES2CES1MEN1
SCHEMBL17200993 1.00 CA1 (0.61) CA1CA2CES2CES1MEN1
SCHEMBL26147589 0.86 CA1 (0.59) CA1CA2CES2CES1MEN1
SCHEMBL13895214 0.86 CYP1A2 (0.62) CA1CA2CES2CES1MEN1
SCHEMBL19299853 0.85 CA1 (0.57) CA1CA2CES2CES1MEN1
SCHEMBL8042558 0.85 CA1 (0.60) CA1CA2CES2CES1MEN1
SCHEMBL8042563 0.85 CA1 (0.60) CA1CA2CES2CES1MEN1
SCHEMBL2019776 0.84 CA1 (0.61) CA1CA2CES2CES1MEN1
SCHEMBL6655419 0.82 CA1 (0.59) CA1CA2CES2CES1PARP1
SCHEMBL6655424 0.82 CA1 (0.59) CA1CA2CES2CES1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9327281-B2 Carbon-dioxide compound and catalyst MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-05-03 US disclosed
US-20150306590-A1 CARBON-DIOXIDE COMPOUND AND CATALYST MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150306590-A1 CARBON-DIOXIDE COMPOUND AND CATALYST MT-CO2, CNOT9, SCO2 CA1 144/4885CA2 26/4885CES2 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.